Mayo Pujols
Equibles does not estimate personal net worth.
Get an email with a short summary when Kyverna Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get KYTX alertsAbout Mayo Pujols
Mayo Pujols is recorded as CTO at Kyverna Therapeutics, Inc. (KYTX). The newest filing on record that lists Mayo Pujols as CTO at Kyverna Therapeutics, Inc. (KYTX) is dated April 13, 2026. Kyverna Therapeutics, Inc. reported in an 8-K filed February 3, 2026 that Mayo Pujols was appointed Chief Technology Officer, effective February 9, 2026. Kyverna Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Kyverna Therapeutics, Inc. includes Warner Biddle (CEO and Board Member), Christi Shaw (Chairman and Board Member), Greg Martini (CFO) and 7 others.
“On February 3, 2026, the Company issued a press release announcing the appointment of Mayo Pujols as the Company's Chief Technology Officer, effective February 9, 2026.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 13, 2026
Company network
Leadership on record at Kyverna Therapeutics, Inc.
- Warner Biddle CEO, Board Member
- Christi Shaw Chairman, Board Member
- Greg Martini CFO
- Gregory Martini CFO, Chief Accounting Officer
- Marc Grasso CFO
- Marc Grasso, M.D. CFO
- Andrew Miller Board Member
- Andrew Miller, Ph.D. Board Member
- Beth Seidenberg Board Member
- Fred E. Cohen Board Member